NCT07435012

Androgenic Alopecia TH07 Clinical Trial

Phase III, Parallel Design, Triple-Blind, Randomized, Multicenter Clinical Trial to Evaluate Safety & Efficacy of TH07 Topical Treatment in Male Patients With Androgenic Alopecia.

• Status: Recruiting
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 420 (estimated)
• Sponsor: Triple Hair Inc · Industry
• Sex: Male
• Age: 18 Years – 49 Years
• Healthy volunteers: Not accepted

Summary

The goal of this clinical trial is to learn whether a new topical solution, TH07, can help treat androgenic alopecia in men and to learn more about its safety. Participants will be asked to apply either the TH07 solution, a standard hair growth treatment (Minoxidil 5%), or a placebo every day for 24 weeks. At the end of the study, hair growth will be compared in each group to determine which treatment is most effective at increasing hair count.

Detailed description

The MATT study is a Phase III clinical trial designed to evaluate the safety and effectiveness of a new topical hair growth treatment called TH07. TH07 is a combined topical spray solution containing three active ingredients commonly used to treat hair loss: Minoxidil (5%) Finasteride (0.1%) and Latanoprost (0.03%). The study plans to enroll 420 men aged 18 to 49 years old across up to 10 clinical sites. Participants will be randomly assigned to one of four groups to receive either TH07 (once or twice daily), a standard Minoxidil solution, or a placebo. The treatment will be applied daily (once or twice) for 24 weeks.

Conditions

• Androgenic Alopecia

Interventions

Type	Name	Description
DRUG	TH07	TH07 (5%Minoxidil, 0.1%Finasteride, 0.03%Latanoprost); topical solution; twice a day
DRUG	TH07	* TH07 (5%Minoxidil, 0.1%Finasteride, 0.03%Latanoprost); topical solution; once a day * Placebo; topical solution; once a day
DRUG	Minoxidil 5% Topical Solution	Minoxidil 5%; topical solution; twice a day
OTHER	Placebo	Placebo; topical solution; twice a day

Timeline

• Start date: 2026-04-01
• Primary completion: 2027-12-01
• Completion: 2028-04-01
• First posted: 2026-02-27
• Last updated: 2026-03-16

Locations

1 site across 1 country: Canada